Rhodosporidium toruloides-a new surrogate model to study rapamycin induced effects on human aging and cancer

Philipp M Cavelius1, Martina Haack1, Dania Awad1

  • 1Department of Chemistry, Werner Siemens-Chair of Synthetic Biotechnology, Technical University of Munich (TUM), Garching, Germany.

Insights

Rhodosporidium toruloides yeast, a model for studying cellular lipid accumulation, shows differential responses to the Target of Rapamycin (TOR) inhibitor rapamycin between its two haplotypes, IFO0559 and IFO0880.

Area of Science:

  • Microbiology
  • Biochemistry
  • Cell Biology

Background:

  • Rhodosporidium toruloides is an oleaginous yeast known for accumulating lipids and carotenoids under stress.
  • Target of Rapamycin (TOR) signaling regulates cellular lipid accumulation and is crucial for cell proliferation.
  • R. toruloides possesses a single TOR kinase, unlike S. cerevisiae, making it a relevant model for mammalian systems.

Purpose of the Study:

  • To investigate the differential cellular response of two R. toruloides haplotypes (IFO0559 and IFO0880) to rapamycin treatment.
  • To analyze differences in lipid and carotenoid accumulation and proteomic profiles between haplotypes.
  • To evaluate R. toruloides as a model for studying rapamycin response in lipid-rich systems relevant to cancer and aging.

Main Methods:

  • Proteomics-centered approach.
  • Treatment of R. toruloides haplotypes IFO0559 and IFO0880 with the TOR inhibitor rapamycin.
  • Analysis of differential protein expression, lipid accumulation, and carotenoid production.

Main Results:

  • One haplotype (IFO0880) exhibited severe growth arrest upon rapamycin treatment, while the other (IFO0559) did not.
  • Proteomic analysis revealed differential expression of proteins involved in cell cycle control, lipogenesis, amino acid metabolism, and autophagy.
  • Identified proteins with known roles in mammalian oncogenesis and aging.

Conclusions:

  • R. toruloides exhibits haplotype-specific responses to rapamycin, highlighting the importance of genetic background.
  • The differential response suggests R. toruloides can serve as a valuable model for studying rapamycin's effects on lipid metabolism.
  • This yeast model is promising for investigating cellular mechanisms in cancer and age-related diseases characterized by high lipid content.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K